Trial Profile
An Open-Label [11C]T-773 Positron Emission Tomography Study to Determine Phosphodiesterase10A Occupancy by TAK-063 After a Single Oral Dose in Human Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Balipodect (Primary) ; T 773 (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Takeda
- 04 Mar 2015 New trial record